Do the clinical gains offered by these drugs in treating specific cancer indications justify the price increases? Schaeffer Center researchers Alice Chen and Dana Goldman explore how we might measure the value of these drugs.
A new analysis finds at least three quarters of the improvement in readmission rates by hospitals who had poor baseline performance was due to regression to the mean (i.e. statistical luck) rather than the policy.
Hospitals in Miami produced 13 percent fewer high-quality hospital stays than the U.S. average, while hospitals in Everett, Washington, a city 25 miles north of Seattle, perform over 20 percent better than average on value.
The proportion of settlements related to psychiatric emergencies has increased in recent years, suggesting the need for more resources to improve access and quality of care for patients with psychiatric emergencies.
Jacobson and Alpert studied more than 2.4 million monthly claims for chemotherapy treatment and found little impact on outpatient chemotherapy treatment for the majority of oncology drugs identified as experiencing shortages between 2004 and 2011.